RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+13.86%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$5.94B
AUM Growth
+$5.94B
(-0.87%)
Cap. Flow
-$357M
Cap. Flow
% of AUM
-6.02%
Top 10 Holdings %
Top 10 Hldgs %
66.2%
Holding
90
New
5
Increased
9
Reduced
10
Closed
27
Top Buys
| 1 |
Cidara Therapeutics
CDTX
|
$111M |
| 2 |
Taysha Gene Therapies
TSHA
|
$29.3M |
| 3 |
Avidity Biosciences
RNA
|
$27.4M |
| 4 |
HNGE
Hinge Health, Inc.
HNGE
|
$15.5M |
| 5 |
Tyra Biosciences
TYRA
|
$14.9M |
Top Sells
| 1 |
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
|
$81.2M |
| 2 |
Apogee Therapeutics
APGE
|
$58.6M |
| 3 |
Zai Lab
ZLAB
|
$46.8M |
| 4 |
Day One Biopharmaceuticals
DAWN
|
$45.6M |
| 5 |
UroGen Pharma
URGN
|
$35.5M |
Sector Composition
| 1 | Healthcare | 99.82% |
| 2 | Financials | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Insmed
INSM
$30.3B
| – | – |
-200,000
| Closed | -$15.3M |
|
|
ITOS
77
DELISTED
iTeos Therapeutics
ITOS
| – | – |
-3,649,057
| Closed | -$21.8M |
|
78
Kura Oncology
KURA
$716M
| – | – |
-4,004,610
| Closed | -$26.4M |
|
79
Lexeo Therapeutics
LXEO
$266M
| – | – |
-546,554
| Closed | -$1.9M |
|
80
Nurix Therapeutics
NRIX
$706M
| – | – |
-1,333,333
| Closed | -$15.8M |
|
81
Scilex Holding
SCLX
$130M
| – | – |
-1,036,218
| Closed | -$258K |
|
82
Sera Prognostics
SERA
$124M
| – | – |
-3,032,808
| Closed | -$11.2M |
|
83
Sutro Biopharma
STRO
$84.5M
| – | – |
-4,434,637
| Closed | -$2.89M |
|
|
84
UroGen Pharma
URGN
$881M
| – | – |
-3,206,271
| Closed | -$35.5M |
|
85
Xencor
XNCR
$586M
| – | – |
-575,000
| Closed | -$6.12M |
|
|
86
Zai Lab
ZLAB
$3.5B
| – | – |
-1,295,040
| Closed | -$46.8M |
|
87
Zura Bio
ZURA
$130M
| – | – |
-3,217,503
| Closed | -$4.15M |
|
|
BOLD
88
Boundless Bio
BOLD
$25.5M
| – | – |
-2,180,631
| Closed | -$3.29M |
|
|
BIOA
89
BioAge Labs, Inc. Common Stock
BIOA
$168M
| – | – |
-1,052,494
| Closed | -$3.96M |
|
|
CBLL
90
CeriBell, Inc. Common Stock
CBLL
$420M
| – | – |
-824,582
| Closed | -$15.8M |
|